Global Cardiac Medical Devices market cagr 9.9%

Cardiac Medical Devices Market

Request Sample Report

Cardiac Medical Devices Market Size and Growth

The global Cardiac Medical Devices market is anticipated to reach a value of $70 billion by 2025, growing at a CAGR of 6%. Key factors driving market growth include technological advancements, increasing prevalence of cardiac diseases, and growing demand for minimally invasive procedures. Increasing adoption of advanced cardiac devices is also contributing to market growth. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Boston Scientific

◍ LivaNova

◍ Medtronic

◍ Abbott

◍ Biotronik

◍ Cardiac Science (subsidiary of Opto Circuits)

◍ Colibri Heart Valve

◍ Edwards Lifesciences

◍ Abbott Laboratories

◍ Cardinal Health

◍ Getinge

◍ Terumo

◍ W. L. Gore & Associates

◍ Lepu Medical Technology

◍ HeartWare

◍ Innomed

◍ M&B Electronic Instruments

◍ Mindray Medical

The cardiac medical devices market is highly competitive, with key players such as Boston Scientific, Medtronic, Abbott, and Edwards Lifesciences dominating the market. These companies provide a wide range of cardiac devices including pacemakers, stents, and defibrillators, contributing to the growth of the market.

- Boston Scientific: $8.39 billion (2020)

- Medtronic: $31.85 billion (2020)

- Abbott: $34.61 billion (2020)

Request Sample Report

Market Segmentation

By Application

◍ Diagnosing and treating heart disease

◍ Treating heart disease

By Product

◍ Cardiac Rhythm Management (CRM) Devices ◍ Cardiac Assist Devices ◍ Heart Valve

Others

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD